Cancer Cell
Volume 27, Issue 1, 12 January 2015, Pages 12-14
Journal home page for Cancer Cell

Preview
Biomarkers in Cancer Immunotherapy

https://doi.org/10.1016/j.ccell.2014.12.004Get rights and content
Under an Elsevier user license
open archive

Antibodies against T cell checkpoint molecules have started to revolutionize cancer treatment. Nevertheless, less than half of all patients respond to these immunotherapies. Recent work supports the potential value of biomarkers that predict therapy outcome and inspires the development of assay systems that interrogate other aspects of the cancer-immunity cycle.

Cited by (0)